News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Telix Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
Market highlights and 5 ASX small caps to watch on Wednesday
Health & Biotech
HealthKick Podcast: Dr Chris Behrenbruch on taking Telix Pharma to $1bn and the future of nuclear medicine
Health & Biotech
Clinical Trials Tracker: 2022 and beyond
News
Last Orders: Small caps hit another 12-year high ahead of holiday
News
ScoPo’s powerplays: Morgans’ healthcare picks for 2021
Health & Biotech
Initial trial results bolster evidence for Telix’s brain cancer treatment
News
Last Orders: What you might have missed on the ASX today
News
Last Orders: What you might have missed on the ASX today
News
ScoPo’s powerplays: ‘Santa is smiling on the markets’
News
Last Orders: What you might have missed on the ASX today
News
Last Orders: What you might have missed on the ASX today
News
Rise & Shine: What you need to know before the ASX opens
Experts
ScoPo’s powerplays: Healthcare hit by ‘Covid exit trade’, but opportunities remain
Health & Biotech
Check Up: Rhythm leads ASX health stocks on progress on replacement for poo tests
News
Last Orders: What you might have missed on the ASX today
News
Last Orders: What you might have missed on the ASX today
Experts
